Multiparameter flow cytometry enables immune profiling and IFN pathway analysis in human minor salivary glands

TL;DR

This study develops a flow cytometry protocol to analyze immune and epithelial cells in human salivary glands, revealing interferon pathway activity in Sjögren's Disease.

Contribution

A novel flow cytometry protocol for immune profiling and interferon pathway analysis in human minor salivary glands is developed and validated.

Findings

Optimized dissociation and permeabilization protocols preserved key cell surface markers in minor salivary glands.

The protocol identified immune cell populations and epithelial cells via cytokeratin-18 staining.

Interferon pathway activity was differentially detected in Sjögren's Disease versus healthy gland cells.

Abstract

We aimed to achieve direct quantitative measurement of activated and therapeutically actionable pathways (e.g., Type-I interferon) in target organs of autoimmune disease using flow cytometry of human salivary glands. Sjögren's Disease (SjD) is a systemic autoimmune disorder characterized by lymphocytic inflammation and dysfunction of the lacrimal and salivary glands. Minor salivary glands are routinely biopsied and are used for the histopathological diagnosis of SjD. In this study, we optimized the dissociation, permeabilization, antibody panel, and analytical parameters to characterize both the immune and epithelial cells in the glands, and the activation status of a specified pathway by measuring intracellular phosphorylated proteins.

Fresh human MSG biopsies were dissociated into single-cell suspensions and permeabilized under optimized conditions. MSG suspensions were stained for cell surface and intracellular markers then analyzed using nine-color conventional flow cytometry, including two intracellular markers.

Our optimized dissociation and permeabilization protocols for human MSG preserved key cell surface markers. Our flow cytometry panel identified major immune cell populations and distinguished epithelial cells via cytokeratin-18. We demonstrate the protocol's utility showing differential interferon pathway activity in SjD vs. healthy MSG leukocytes and epithelial cells. We provide guidance on panel selection, analytical capabilities, and the impact of cell yield on resolution using conventional flow cytometry.

Our optimized protocol enables high-resolution characterization of immune and epithelial cell populations in human MSG, preserving key markers and capturing interferon pathway activity. Our protocol provides a robust framework for the direct study of immune heterogeneity and signaling dynamics in SjD at single cell resolution.

Figures